Niacinamide: Hot cht gip ci thin mu da, h tr nui dng, phc hi da cng nh se kht l chn
Combining DSIP with other treatments should be approached cautiously to avoid over-sedation, drug interactions, or adverse effects
The relationship between weight loss medications and sexual function is complex and multifactorial, involving physiological, psychological, and hormonal mechanisms
Tirzepatide is a combination GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) agonist
UK product information advises that patients should: Recognise symptoms of pancreatitis (severe, persistent abdominal pain radiating to the back, nausea, vomiting) Seek immediate medical attention if these symptoms develop Discontinue the medicine if pancreatitis is suspected Not restart the GLP-1 medicine if pancreatitis is confirmed Patients should also be aware of an increased risk of gallbladder disease (gallstones, cholecystitis) with GLP-1 medicines, which can present with similar abdominal symptoms and requires prompt medical attention
Public Health 8, 574111